F-18 Fluorodeoxyglucose Positron Emission Tomography in Pulmonary Cryptococcoma

Chung-Huei Hsu, Chi-Ming Lee, Fong Chieh Wang, Yun-Ho Lin

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

Cryptococcosis is not uncommon. Potential interpretation pitfalls should be kept in mind when fluorodeoxyglucose (FDG) positron emission tomography (PET) is used for differentiating pulmonary nodules and for discriminating infection from malignancy, especially in areas where the prevalence of granulomatous infection is high and in immunocompromised patients. In this case, a nodular mass was shown on chest radiography and computed tomographic (CT) scanning. A consolidated infection or a bronchioloalveolar carcinoma was suspected because the CT scan showed air bronchograms within the mass and another perihilar infiltration. The FDG PET scan clearly delineated the lesion and had intermediately high glucose uptake (standard uptake value, 3.8-4.0), which led to the exclusion of the possibility of bronchioloalveolar carcinoma because most of these tumors had normal or mildly increased FDG accumulation. Cryptococcoma was finally diagnosed. Hence, the CT scan and FDG PET played complementary roles in the differential diagnosis of this nodular mass.

Original languageEnglish
Pages (from-to)791-793
Number of pages3
JournalClinical Nuclear Medicine
Volume28
Issue number9
DOIs
Publication statusPublished - Sep 2003

Fingerprint

Fluorodeoxyglucose F18
Positron-Emission Tomography
Bronchiolo-Alveolar Adenocarcinoma
Lung
Infection
Cryptococcosis
Immunocompromised Host
Radiography
Neoplasms
Differential Diagnosis
Thorax
Air
Glucose

Keywords

  • Cryptococcosis
  • PET

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Radiological and Ultrasound Technology

Cite this

F-18 Fluorodeoxyglucose Positron Emission Tomography in Pulmonary Cryptococcoma. / Hsu, Chung-Huei; Lee, Chi-Ming; Wang, Fong Chieh; Lin, Yun-Ho.

In: Clinical Nuclear Medicine, Vol. 28, No. 9, 09.2003, p. 791-793.

Research output: Contribution to journalArticle

@article{e4a661e2285742f7a3cb239b6adbfdf9,
title = "F-18 Fluorodeoxyglucose Positron Emission Tomography in Pulmonary Cryptococcoma",
abstract = "Cryptococcosis is not uncommon. Potential interpretation pitfalls should be kept in mind when fluorodeoxyglucose (FDG) positron emission tomography (PET) is used for differentiating pulmonary nodules and for discriminating infection from malignancy, especially in areas where the prevalence of granulomatous infection is high and in immunocompromised patients. In this case, a nodular mass was shown on chest radiography and computed tomographic (CT) scanning. A consolidated infection or a bronchioloalveolar carcinoma was suspected because the CT scan showed air bronchograms within the mass and another perihilar infiltration. The FDG PET scan clearly delineated the lesion and had intermediately high glucose uptake (standard uptake value, 3.8-4.0), which led to the exclusion of the possibility of bronchioloalveolar carcinoma because most of these tumors had normal or mildly increased FDG accumulation. Cryptococcoma was finally diagnosed. Hence, the CT scan and FDG PET played complementary roles in the differential diagnosis of this nodular mass.",
keywords = "Cryptococcosis, PET",
author = "Chung-Huei Hsu and Chi-Ming Lee and Wang, {Fong Chieh} and Yun-Ho Lin",
year = "2003",
month = "9",
doi = "10.1097/01.rlu.0000082680.98898.2b",
language = "English",
volume = "28",
pages = "791--793",
journal = "Clinical Nuclear Medicine",
issn = "0363-9762",
publisher = "Lippincott Williams and Wilkins",
number = "9",

}

TY - JOUR

T1 - F-18 Fluorodeoxyglucose Positron Emission Tomography in Pulmonary Cryptococcoma

AU - Hsu, Chung-Huei

AU - Lee, Chi-Ming

AU - Wang, Fong Chieh

AU - Lin, Yun-Ho

PY - 2003/9

Y1 - 2003/9

N2 - Cryptococcosis is not uncommon. Potential interpretation pitfalls should be kept in mind when fluorodeoxyglucose (FDG) positron emission tomography (PET) is used for differentiating pulmonary nodules and for discriminating infection from malignancy, especially in areas where the prevalence of granulomatous infection is high and in immunocompromised patients. In this case, a nodular mass was shown on chest radiography and computed tomographic (CT) scanning. A consolidated infection or a bronchioloalveolar carcinoma was suspected because the CT scan showed air bronchograms within the mass and another perihilar infiltration. The FDG PET scan clearly delineated the lesion and had intermediately high glucose uptake (standard uptake value, 3.8-4.0), which led to the exclusion of the possibility of bronchioloalveolar carcinoma because most of these tumors had normal or mildly increased FDG accumulation. Cryptococcoma was finally diagnosed. Hence, the CT scan and FDG PET played complementary roles in the differential diagnosis of this nodular mass.

AB - Cryptococcosis is not uncommon. Potential interpretation pitfalls should be kept in mind when fluorodeoxyglucose (FDG) positron emission tomography (PET) is used for differentiating pulmonary nodules and for discriminating infection from malignancy, especially in areas where the prevalence of granulomatous infection is high and in immunocompromised patients. In this case, a nodular mass was shown on chest radiography and computed tomographic (CT) scanning. A consolidated infection or a bronchioloalveolar carcinoma was suspected because the CT scan showed air bronchograms within the mass and another perihilar infiltration. The FDG PET scan clearly delineated the lesion and had intermediately high glucose uptake (standard uptake value, 3.8-4.0), which led to the exclusion of the possibility of bronchioloalveolar carcinoma because most of these tumors had normal or mildly increased FDG accumulation. Cryptococcoma was finally diagnosed. Hence, the CT scan and FDG PET played complementary roles in the differential diagnosis of this nodular mass.

KW - Cryptococcosis

KW - PET

UR - http://www.scopus.com/inward/record.url?scp=1242282675&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=1242282675&partnerID=8YFLogxK

U2 - 10.1097/01.rlu.0000082680.98898.2b

DO - 10.1097/01.rlu.0000082680.98898.2b

M3 - Article

C2 - 12973014

AN - SCOPUS:1242282675

VL - 28

SP - 791

EP - 793

JO - Clinical Nuclear Medicine

JF - Clinical Nuclear Medicine

SN - 0363-9762

IS - 9

ER -